Skip to main content
Erschienen in: Endocrine 3/2018

02.07.2018 | Research Letter

Autoimmune pituitary involvement in Prader–Willi syndrome: new perspective for further research

verfasst von: Graziano Grugni, Antonino Crinò, Annamaria De Bellis, Alessio Convertino, Sarah Bocchini, Sabrina Maestrini, Paolo Cirillo, Silvana De Lucia, Maurizio Delvecchio, on behalf of the Italian Autoimmune Hypophysitis Network Study and of the Genetic Obesity Study Group of the Italian Society of Pediatric Endocrinologyand Diabetology (ISPED)

Erschienen in: Endocrine | Ausgabe 3/2018

Einloggen, um Zugang zu erhalten

Abstract

The role of antipituitary antibodies in the pathophysiology of pituitary hormone deficiency has been increasingly elucidated over the last decade. Prader-Willi syndrome is a genetic disorder which includes hypothalamic/pituitary dysfunction as one of its main features. We looked for autoimmune pituitary involvement in 55 adults with Prader-Willi syndrome, discovering that about 30% of them have a positive titer of antipituitary antibodies. Although the presence of these autoantibodies could only be an “epiphenomenon”, our results suggest that autoimmune mechanisms might contribute, at least in part, to the pituitary impairment of Prader-Willi syndrome, and in addition to genetically determined dysfunction of the central nervous system. This paper provides a new perspective on pituitary impairment in these patients, suggesting that the search for hypophisitis could be a reasonable and interesting field for further research.
Literatur
1.
Zurück zum Zitat S.B. Cassidy, S. Schwartz, J.L. Miller, D.J. Driscoll, Prader-Willi syndrome. Genet. Med. 14(1), 10–26 (2012)PubMedCrossRef S.B. Cassidy, S. Schwartz, J.L. Miller, D.J. Driscoll, Prader-Willi syndrome. Genet. Med. 14(1), 10–26 (2012)PubMedCrossRef
3.
Zurück zum Zitat M.A. Angulo, M.G. Butler, M.E. Cataletto, Prader-Willi syndrome: a review of clinical, genetic, and endocrine findings. J. Endocrinol. Invest. 38(12), 1249–1263 (2015)PubMedPubMedCentralCrossRef M.A. Angulo, M.G. Butler, M.E. Cataletto, Prader-Willi syndrome: a review of clinical, genetic, and endocrine findings. J. Endocrinol. Invest. 38(12), 1249–1263 (2015)PubMedPubMedCentralCrossRef
4.
Zurück zum Zitat G. Bellastella, M.I. Maiorino, A. Bizzarro et al. Revisitation of autoimmune hypophysitis: knowledge and uncertainties on pathophysiological and clinical aspects. Pituitary 19(6), 625–642 (2016)PubMedCrossRef G. Bellastella, M.I. Maiorino, A. Bizzarro et al. Revisitation of autoimmune hypophysitis: knowledge and uncertainties on pathophysiological and clinical aspects. Pituitary 19(6), 625–642 (2016)PubMedCrossRef
5.
Zurück zum Zitat A. De Bellis, A. Bizzarro, M. Conte et al. Antipituitary antibodies in adults with apparently idiopathic growth hormone deficiency and in adults with autoimmune endocrine diseases. J. Clin. Endocrinol. Metab. 88, 650–654 (2003)PubMedCrossRef A. De Bellis, A. Bizzarro, M. Conte et al. Antipituitary antibodies in adults with apparently idiopathic growth hormone deficiency and in adults with autoimmune endocrine diseases. J. Clin. Endocrinol. Metab. 88, 650–654 (2003)PubMedCrossRef
6.
Zurück zum Zitat A. Ricciuti, A. De Remigis, M.A. Landek-Salgado et al. Detection of pituitary antibodies by immunofluorescence: approach and results in patients with pituitary diseases. J. Clin. Endocrinol. Metab. 99(5), 1758–1766 (2014)PubMedPubMedCentralCrossRef A. Ricciuti, A. De Remigis, M.A. Landek-Salgado et al. Detection of pituitary antibodies by immunofluorescence: approach and results in patients with pituitary diseases. J. Clin. Endocrinol. Metab. 99(5), 1758–1766 (2014)PubMedPubMedCentralCrossRef
7.
Zurück zum Zitat G. Bellastella, M. Rotondi, E. Pane et al. Predictive role of the immunostaining pattern of immunofluorescence and the titers of antipituitary antibodies at presentation for the occurrence of autoimmune hypopituitarism in patients with autoimmune polyendocrine syndromes over a five-year follow-up. J. Clin. Endocrinol. Metab. 95, 3750–3757 (2010)PubMedCrossRef G. Bellastella, M. Rotondi, E. Pane et al. Predictive role of the immunostaining pattern of immunofluorescence and the titers of antipituitary antibodies at presentation for the occurrence of autoimmune hypopituitarism in patients with autoimmune polyendocrine syndromes over a five-year follow-up. J. Clin. Endocrinol. Metab. 95, 3750–3757 (2010)PubMedCrossRef
8.
Zurück zum Zitat A. De Bellis, G. Bellastella, M.I. Maiorino et al. Longitudinal behavior of autoimmune GH deficiency: from childhood to transition age. Eur. J. Endocrinol. 174(3), 381–387 (2016)PubMedCrossRef A. De Bellis, G. Bellastella, M.I. Maiorino et al. Longitudinal behavior of autoimmune GH deficiency: from childhood to transition age. Eur. J. Endocrinol. 174(3), 381–387 (2016)PubMedCrossRef
9.
Zurück zum Zitat A. De Bellis, A. Dello Iacovo, G. Bellastella et al. Characterization of pituitary cells targeted by antipituitary antibodies in patients with isolated autoimmune diseases without pituitary insufficiency may help to foresee the kind of future hypopituitarism. Pituitary 17(5), 457–463 (2014)PubMedCrossRef A. De Bellis, A. Dello Iacovo, G. Bellastella et al. Characterization of pituitary cells targeted by antipituitary antibodies in patients with isolated autoimmune diseases without pituitary insufficiency may help to foresee the kind of future hypopituitarism. Pituitary 17(5), 457–463 (2014)PubMedCrossRef
10.
Zurück zum Zitat G. Grugni, E. Marostica, A. Crinò et al. Deconvolution-based assessment of pituitary GH secretion stimulated with GHRH + arginine in Prader-Willi adults and obese controls. Clin. Endocrinol. 79(2), 224–233 (2013)CrossRef G. Grugni, E. Marostica, A. Crinò et al. Deconvolution-based assessment of pituitary GH secretion stimulated with GHRH + arginine in Prader-Willi adults and obese controls. Clin. Endocrinol. 79(2), 224–233 (2013)CrossRef
11.
Zurück zum Zitat L.C. Burnett, C.A. LeDuc, C.R. Sulsona et al. Deficiency in prohormone convertase PC1 impairs prohormone processing in Prader-Willi syndrome. J. Clin. Invest. 127(1), 293–305 (2017)PubMedCrossRef L.C. Burnett, C.A. LeDuc, C.R. Sulsona et al. Deficiency in prohormone convertase PC1 impairs prohormone processing in Prader-Willi syndrome. J. Clin. Invest. 127(1), 293–305 (2017)PubMedCrossRef
12.
Zurück zum Zitat F. Tanriverdi, A. De Bellis, M. Battaglia et al. Investigation of antihypothalamus and antipituitary antibodies in amateur boxers: is chronic repetitive head trauma-induced pituitary dysfunction associated with autoimmunity? Eur. J. Endocrinol. 162(5), 861–867 (2010)PubMedCrossRef F. Tanriverdi, A. De Bellis, M. Battaglia et al. Investigation of antihypothalamus and antipituitary antibodies in amateur boxers: is chronic repetitive head trauma-induced pituitary dysfunction associated with autoimmunity? Eur. J. Endocrinol. 162(5), 861–867 (2010)PubMedCrossRef
13.
Zurück zum Zitat A.E. Rigamonti, G. Grugni, N. Marazzi et al. Unaltered ratio of circulating levels of growth hormone/GH isoforms in adults with Prader-Willi syndrome after GHRH plus arginine administration. Growth Horm. IGF Res. 25(4), 168–173 (2015)PubMedCrossRef A.E. Rigamonti, G. Grugni, N. Marazzi et al. Unaltered ratio of circulating levels of growth hormone/GH isoforms in adults with Prader-Willi syndrome after GHRH plus arginine administration. Growth Horm. IGF Res. 25(4), 168–173 (2015)PubMedCrossRef
Metadaten
Titel
Autoimmune pituitary involvement in Prader–Willi syndrome: new perspective for further research
verfasst von
Graziano Grugni
Antonino Crinò
Annamaria De Bellis
Alessio Convertino
Sarah Bocchini
Sabrina Maestrini
Paolo Cirillo
Silvana De Lucia
Maurizio Delvecchio
on behalf of the Italian Autoimmune Hypophysitis Network Study and of the Genetic Obesity Study Group of the Italian Society of Pediatric Endocrinologyand Diabetology (ISPED)
Publikationsdatum
02.07.2018
Verlag
Springer US
Erschienen in
Endocrine / Ausgabe 3/2018
Print ISSN: 1355-008X
Elektronische ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-018-1666-5

Weitere Artikel der Ausgabe 3/2018

Endocrine 3/2018 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.